AACA is an inhibitor for sclerostin , that binds sclerostin on loop3 region with K d of 15.4 nM. AACA exhibits anti-osteoporosis activity through Wnt signaling pathway.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Wnt
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.